Compare NUVB & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | CNXN |
|---|---|---|
| Founded | 2018 | 1982 |
| Country | United States | United States |
| Employees | 298 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 1997 |
| Metric | NUVB | CNXN |
|---|---|---|
| Price | $4.48 | $63.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 44.5K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | N/A |
| Revenue This Year | $203.82 | $6.24 |
| Revenue Next Year | $58.18 | $4.39 |
| P/E Ratio | ★ N/A | $94.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $54.97 |
| 52 Week High | $9.75 | $71.17 |
| Indicator | NUVB | CNXN |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 59.52 |
| Support Level | $4.06 | $56.14 |
| Resistance Level | $5.42 | $64.84 |
| Average True Range (ATR) | 0.26 | 1.53 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 26.05 | 37.26 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.